Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI) Treated With Multitarget Antiviral Therapy (MT-ART)

NCT04225325 is registered in ClinicalTrials.gov with ADRIANO LAZZARIN, MD as lead sponsor.

NCT NCT04225325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04225325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI) Treated With Multitarget Antiviral Therapy (MT-ART)
Lead sponsor
ADRIANO LAZZARIN, MD
Phase
Phase 4
Overall status
Unknown status
Start date
May 7, 2018
Completion date
June 14, 2021
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection